A proposal for standardized grading of chronic changes in native kidney biopsy specimens
Sanjeev Sethi(Mayo Clinic), Mark Haas(Cedars-Sinai Medical Center), Robert B. Colvin(Harvard University), An S. De Vriese(Ghent University), Loren P. Herrera Hernandez(Mayo Clinic), Michael Mengel(University of Alberta), Neeraja Kambham(Stanford Medicine), Agnes B. Fogo(Vanderbilt University Medical Center), Andrew D. Rule(Mayo Clinic), Karl A. Nath(Mayo Clinic), Brad H. Rovin(The Ohio State University Wexner Medical Center), Anthony Chang(University of Chicago), Surya V. Seshan(Cornell University), Fernando C. Fervenza(Mayo Clinic), Ingeborg M. Bajema(University Medical Center Groningen), Cynthia C. Nast(Cedars-Sinai Medical Center), Richard J. Glassock(University of California, Los Angeles), Sundaram Hariharan(University of Pittsburgh Medical Center), Jai Radhakrishnan(Columbia University), Vivette D. D’Agati(Columbia University), Lorraine C. Racusen(Johns Hopkins University), H. Terence Cook(Hammersmith Hospital), Glen S. Markowitz(Columbia University Irving Medical Center), Christopher G. Winearls(Mayo Clinic), Helmut G. Rennke(Brigham and Women's Hospital), Gerald B. Appel(Columbia University Irving Medical Center), Pierre Ronco(Inserm)
Cited by 278
Related Papers
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
|American Journal of Transplantation|2008|1.9k
Reactivity of a monoclonal antibody with human ovarian carcinoma.
|Journal of Clinical Investigation|1981|1.7k